Quality of life assessment following peptide receptor radionuclide therapy (PRRT) of pancreatic neuroendocrine tumor (P-NET)

被引：0
|
作者：
Marinova, Milka [3 ]
Muecke, Martin [1 ]
Mahlberg, Lukas [2 ]
Essler, Markus [2 ]
Cuhls, Henning [1 ]
Radbruch, Lukas [1 ]
Ahmadzadehfar, Hojjat [2 ]
机构：
[1] Univ Hosp Bonn, Bonn, Germany
[2] Univ Hosp Bonn, Nucl Med, Bonn, Germany
[3] Univ Hosp Bonn, Radiol, Bonn, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1462
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Retrospective analysis of Peptide Receptor Radionuclide Therapy (PRRT) in Japanese patients with unresectable neuroendocrine tumor.
    Kobayashi, Noritoshi
    Wild, Damian
    Kaul, Felix
    Ichikawa, Yasushi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Peptide Receptor Radionuclide Therapy (PRRT) and impact on quality of life in patients with neuroendocrine neoplasms: An international multi-centre study
    Kong, G.
    Corsini, N.
    Hogg, A.
    Mercurio, J.
    Bailey, D.
    Chan, B.
    Hayes, A.
    Debrabandere, S.
    Laidley, D.
    Patel, D.
    Cehic, G.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 150 - 150
  • [33] Tumor Cystic Necrosis Following Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
    Ladwa, Rahul
    Wen Hong, Hooi
    Wyld, David
    Pattison, David A.
    Burge, Matthew
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (03) : 186 - 187
  • [34] Quality Of Life in Patients with Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy
    Wang, Q.
    Librizzi, D.
    Bagheri, S.
    Ebrahimifard, A.
    Luster, M.
    Yousefi, B. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S246 - S247
  • [35] Circulating Neuroendocrine Tumor Gene Expression for Monitoring Peptide Receptor Radionuclide (PRRT) Efficacy
    Bodei, L.
    Kidd, M.
    Van der Zwan, W.
    Singh, A.
    Severi, S.
    Drozdov, I
    Cwikla, J.
    Kolasinska-Cwikla, A.
    Baum, R. P.
    Paganelli, G.
    Krenning, E.
    Modlin, I
    NEUROENDOCRINOLOGY, 2019, 108 : 113 - 113
  • [36] Efficacy of the Chronic Lanreotide Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP/NET) after Peptide Receptor Radionuclide Therapy (PRRT)
    Szalus, N.
    Kaminski, G.
    Podgajny, Z.
    Dziuk, E.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 137 - 137
  • [37] Reduced efficacy of repeated peptide receptor radionuclide therapy (PRRT) in progressive gastroenteropancreatic neuroendocrine tumours (GEP-NET)?
    Schnurr, J.
    Reimold, M.
    Dittmann, H.
    Kupferschlaeger, J.
    Bares, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S396 - S396
  • [38] Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry
    Hernando Cubero, J.
    Lago, N. Martinez
    Mitjavila, M.
    Garcia-Burillo, A.
    Pubul, V.
    Bello, P.
    Cano, J. M.
    Llana, B.
    Castellon, M.
    Rodeno, E.
    Pineiro, A.
    Soldevilla, C.
    Nevares, M.
    Aller, J.
    Anido Herranz, U.
    Carnero Lopez, B.
    Nogareda, Z.
    Garcia Alvarez, A.
    Jimenez Fonseca, P.
    Capdevila Castillon, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S756 - S756
  • [39] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [40] Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours
    Hallet, Julie
    Soreide, Kjetil
    BRITISH JOURNAL OF SURGERY, 2024, 111 (09)
12345